Arkolith/Insider Trading/CTKB/Form 4

Jeanmonod Patrik

Chief Financial OfficerCytek Biosciences, Inc. (CTKB) · full profile →Form 4 · filed Nov 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21K
Net Open-Market Flow
-$21K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 24, 2023Sell(S)3K$6.94$21K96K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056733) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML